Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Ailem Rabasa"'
Autor:
Greta Garrido, Brett Schrand, Ailem Rabasa, Agata Levay, Francesca D’Eramo, Alexey Berezhnoy, Shrey Modi, Tal Gefen, Koen Marijt, Elien Doorduijn, Vikas Dudeja, Thorbald van Hall, Eli Gilboa
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-13 (2019)
The anti-tumour immune response greatly depends on the number of tumour neoantigens. Here the authors show in mouse models that a therapeutic strategy aimed at increasing the number of neoantigens via downregulating TAP, an antigen processing associa
Externí odkaz:
https://doaj.org/article/9412b6e3bd1140079d62c6a2a9c464d0
Autor:
Brett Schrand, Emily Clark, Agata Levay, Ailem Rabasa Capote, Olivier Martinez, Randall Brenneman, Iris Castro, Eli Gilboa
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-2 (2021)
Externí odkaz:
https://doaj.org/article/5ad18fffa1fe4041b01e90a6279ca15a
Autor:
Brett Schrand, Emily Clark, Agata Levay, Ailem Rabasa Capote, Olivier Martinez, Randall Brenneman, Iris Castro, Eli Gilboa
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Efficient tumor antigen uptake by dendritic cells is facilitated by antibody coating of tumor cells. Here, the authors develop an approach based on hapten vaccination and hapten/tumor targeting ligand conjugates that potentiate anti-tumor immunity by
Externí odkaz:
https://doaj.org/article/2b3fb79e93c34cee87312bf77ce68f7e
Autor:
Greta Garrido, Ailem Rabasa, Cristina Garrido, Lisset Chao, Federico Garrido, Ángel M. García-Lora, Belinda Sánchez-Ramírez
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A growing emphasis is being placed on immune regulator genes that govern tumor – T cell interac
Externí odkaz:
https://doaj.org/article/9283c0866cd44b22bea9c90a40f56446
Autor:
Eli Gilboa, Thorbald van Hall, Vikas Dudeja, W. Martin Kast, Marcin Kortylewski, Deukwoo Kwon, Zhuoran Zhang, Koen A. Marijt, Francesca D'Eramo, Diane M. Da Silva, Anthony Ferrantella, Ailem Rabasa, Agata Levay, Brett Schrand, Greta Garrido
Supplementary Figures and Table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f4758aad3bc5429ecd5a479e1fbe4f7
https://doi.org/10.1158/2326-6066.22544020.v1
https://doi.org/10.1158/2326-6066.22544020.v1
Autor:
Eli Gilboa, Thorbald van Hall, Vikas Dudeja, W. Martin Kast, Marcin Kortylewski, Deukwoo Kwon, Zhuoran Zhang, Koen A. Marijt, Francesca D'Eramo, Diane M. Da Silva, Anthony Ferrantella, Ailem Rabasa, Agata Levay, Brett Schrand, Greta Garrido
Vaccination of patients against neoantigens expressed in concurrent tumors, recurrent tumors, or tumors developing in individuals at risk of cancer is posing major challenges in terms of which antigens to target and is limited to patients expressing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3418e2867451795179a87a948445be83
https://doi.org/10.1158/2326-6066.c.6550510.v1
https://doi.org/10.1158/2326-6066.c.6550510.v1
Autor:
Ailem Rabasa Capote, Eli Gilboa, Agata Levay, Olivier Martinez, Randall Brenneman, Iris Castro, Emily S. Clark, Brett Schrand
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-2 (2021)
Nature Communications
Nature Communications
Uptake of tumor antigens by tumor-infiltrating dendritic cells is limiting step in the induction of tumor immunity, which can be mediated through Fc receptor (FcR) triggering by antibody-coated tumor cells. Here we describe an approach to potentiate
Autor:
Ramírez, Belinda Sánchez, Alpízar, Yeranddy Aguiar, Fernández, Diana Rosa Hernández, Hidalgo, Greta Garrido, Capote, Ailem Rabasa, Rodríguez, Rolando Pérez, Fernández, Luis Enrique
Publikováno v:
In Vaccine 2008 26(38):4918-4926
Autor:
Diane M. Da Silva, Deukwoo Kwon, Francesca D’Eramo, Vikas Dudeja, Thorbald van Hall, Agata Levay, Brett Schrand, Ailem Rabasa, Zhuoran Zhang, Marcin Kortylewski, Koen A. Marijt, Eli Gilboa, Anthony Ferrantella, Greta Garrido, W. Martin Kast
Publikováno v:
Cancer Immunol Res
Cancer Immunology Research, 8(7), 856-868. AMER ASSOC CANCER RESEARCH
Cancer Immunology Research, 8(7), 856-868. AMER ASSOC CANCER RESEARCH
Vaccination of patients against neoantigens expressed in concurrent tumors, recurrent tumors, or tumors developing in individuals at risk of cancer is posing major challenges in terms of which antigens to target and is limited to patients expressing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c60a3c1416f24d4a187076aa4fb03c4
https://doi.org/10.1158/2326-6066.cir-20-0020
https://doi.org/10.1158/2326-6066.cir-20-0020
Autor:
Iris Castro, Ailem Rabasa Capote, Emily S. Clark, Olivier Martinez, Agata Levay, Eli Gilboa, Randall Brenneman, Brett Schrand
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Nature Communications
Nature Communications
Uptake of tumor antigens by tumor-infiltrating dendritic cells is limiting step in the induction of tumor immunity, which can be mediated through Fc receptor (FcR) triggering by antibody-coated tumor cells. Here we describe an approach to potentiate